Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0460
+0.0010 (2.22%)
Aug 21, 2026, 4:10 PM AEST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 168.27 million as of August 21, 2026. Its market cap has increased by 96.15% in one year.
Market Cap
168.27M
Enterprise Value
161.96M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
ChartMarket Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 168.27M, an increase of 1,197.10%. That is a compound annual growth rate of 14.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 168.27M | -13.44% |
| Dec 31, 2025 | 194.40M | 148.21% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 320.45M |
| Orthocell | 216.44M |
| BLS Pharmaceuticals | 213.88M |
| Nyrada | 177.76M |
| Dimerix | 177.12M |
| Island Pharmaceuticals | 134.64M |
| Recce Pharmaceuticals | 113.80M |
| Alterity Therapeutics | 108.75M |